David Goeddel V.
Director, NGM Biopharmaceuticals (United States).
Companies
- Tenaya Therapeutics, Inc.Board member Jul 29, 2021 to now1
- NGM Biopharmaceuticals (United States)Board member Apr 3, 2019 to Apr 8, 20242
- Nurix (United States)Board member Jul 29, 2020 to Jul 29, 20203
- RAPT Therapeutics, Inc.Board member Oct 30, 2019 to Nov 4, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tenaya Therapeutics, Inc. TNYA4,985,570 shares5$1.9M at $0.37Mar 7, 2025
NGM Biopharmaceuticals (United States)1,000 shares6Apr 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 5, 2025Bought 35,714,284 shares at $0.70 of Tenaya Therapeutics, Inc.5
- Apr 5, 2024Other 1,000 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 100,000 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 100,000 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 1,298,908 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 1,298,908 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 2,265,758 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 968,990 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 858,035 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 11,103,333 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 90,442 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 2,650,177 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 949,862 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 190,000 shares of NGM Biopharmaceuticals (United States)6
- Apr 5, 2024Returned to company 134,180 shares of NGM Biopharmaceuticals (United States)6
- Feb 12, 2024Bought 2,222,222 shares at $4.50 of Tenaya Therapeutics, Inc.7
- Nov 16, 2023Bought 5,840 shares at $0.62 of NGM Biopharmaceuticals (United States)8
- Nov 16, 2023Bought 1,460 shares at $0.62 of NGM Biopharmaceuticals (United States)8
- Nov 15, 2023Bought 16,791 shares at $0.71 of NGM Biopharmaceuticals (United States)8
- Nov 15, 2023Bought 2,720 shares at $0.71 of NGM Biopharmaceuticals (United States)8
- Mar 10, 2023Bought 6,779 shares at $2.60 of Tenaya Therapeutics, Inc.9
- Feb 8, 2023Bought 1,500,000 shares at $2.60 of Tenaya Therapeutics, Inc.10
- Jan 31, 2023Bought 176,730 shares at $5.00 of NGM Biopharmaceuticals (United States)11
- Jan 30, 2023Bought 7,542 shares at $5.00 of NGM Biopharmaceuticals (United States)11
- Jan 23, 2023Bought 9,900 shares at $5.00 of NGM Biopharmaceuticals (United States)12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARNurix (United States), Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Feb 14, 2024
- 8SEC EDGARForm 4 filed Nov 17, 2023
- 9SEC EDGARForm 4 filed Mar 14, 2023
- 10SEC EDGARForm 4 filed Feb 10, 2023
- 11SEC EDGARForm 4 filed Feb 1, 2023
- 12SEC EDGARForm 4 filed Jan 25, 2023